Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Bailey

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Pediatric Blood & Cancer|November 9, 2018
The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
Journal of Neuro-Oncology|June 28, 2018
The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
British Journal of Haematology|November 29, 2016
The use of anthracyclines in the treatment of endemic Burkitt lymphomaElizabeth Molyneux, Ed Schwalbe, George Chagaluka, et al.
BMJ Open|June 3, 2021
Acceptance and commitment therapy for young brain tumour survivors: study protocol for an acceptability and feasibility trialSam Malins, Ray Owen, Ingram Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesDavid W Ellison, Mehmet Kocak, James Dalton, et al.
Pediatric Blood & Cancer|January 4, 2018
SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settingsLaila Hessissen, Jeannette Parkes, Nisreen Amayiri, et al.
Acta Neuropathologica|November 4, 2010
MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomasRuth G Tatevossian, Bo Tang, James Dalton, et al.
Pediatric Blood & Cancer|November 25, 2014
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settingsJeannette Parkes, Marc Hendricks, Peter Ssenyonga, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Pediatric Blood & Cancer|January 4, 2018
A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)Scott C Howard, Alan Davidson, Sandra Luna-Fineman, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Pediatric Blood & Cancer|November 9, 2018
The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
Journal of Neuro-Oncology|June 28, 2018
The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic reviewSimon P Stevens, Caroline Main, Simon Bailey, et al.
British Journal of Haematology|November 29, 2016
The use of anthracyclines in the treatment of endemic Burkitt lymphomaElizabeth Molyneux, Ed Schwalbe, George Chagaluka, et al.
BMJ Open|June 3, 2021
Acceptance and commitment therapy for young brain tumour survivors: study protocol for an acceptability and feasibility trialSam Malins, Ray Owen, Ingram Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesDavid W Ellison, Mehmet Kocak, James Dalton, et al.
Pediatric Blood & Cancer|January 4, 2018
SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settingsLaila Hessissen, Jeannette Parkes, Nisreen Amayiri, et al.
Acta Neuropathologica|November 4, 2010
MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomasRuth G Tatevossian, Bo Tang, James Dalton, et al.
Pediatric Blood & Cancer|November 25, 2014
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settingsJeannette Parkes, Marc Hendricks, Peter Ssenyonga, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Pediatric Blood & Cancer|January 4, 2018
A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)Scott C Howard, Alan Davidson, Sandra Luna-Fineman, et al.
Pageof 18